跳至主要内容
临床试验/NL-OMON53388
NL-OMON53388尚未招募2 期

IMPROVE - improving anxiety treatments by modulating emotional memories prior to in vivo exposure: a multiple baseline study - IMPROVE: improving anxiety treatments

niversiteit Utrecht0 个研究点目标入组 8 人开始时间: 待定最近更新:
适应症

试验速览

阶段
2 期
状态
尚未招募
入组人数
8

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 64(—)

入选标准

  • - Patients >=18 years of age
  • - Sufficient mastery of the Dutch language and ability to complete
  • questionnaires and understand informed consent information
  • - Meeting DSM-5 criteria for social anxiety disorder (assessed with
  • MINI-S-DSM-5).
  • - Stable medication for at least six weeks before starting participation in the
  • study and willingness by the patient and physician to keep the medication
  • stable during the study period. The use of sedating medication (e.g.
  • benzodiazepines) is no contraindication however, participants are strongly
  • advised not to use sedating medication prior to- or after treatment sessions
  • and subsequent days. The use of sedating medication will be registered
  • - Self-reported ability to refrain from alcohol or drugs 24 hours before and
  • after each session. General use of alcohol or drugs will be discouraged.

排除标准

  • - Self-reported neurological disorder
  • - Acute or recent history of suicide attempts according to the (MINI-S-DSM-5)
  • - Self-reported visual or auditory impairments that could hinder treatment
  • - Self-reported current psychological treatment for other DSM-5 disorders
  • - Being reluctant or unable to complete questionnaires online

研究者

相似试验